GlassScriptPhysician profile
Mahender K Gaba
NPI 1104896174
$13,253.13
in general payments reported to CMS, 2019-2025
31 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,119 · 2020: $116 · 2021: $1,474 · 2022: $1,326 · 2023: $3,242 · 2024: $3,708 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,428 · Travel and Lodging: $3,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,427.73 |
| Travel and Lodging | $3,790.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,606.53 | 2021-2025 | Turbohawk, Micra, Aurora Ev-Icd Mri Surescan |
| Abiomed | $2,825.10 | 2019-2024 | Impella |
| Boston Scientific Corporation | $960.94 | 2019-2024 | Watchman Flx |
| W. L. Gore & Associates, INC. | $903.96 | 2021 | |
| Novartis Pharmaceuticals Corporation | $624.42 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $548.95 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $303.66 | 2019-2024 | Xarelto |
| Abbott Laboratories | $292.67 | 2023-2025 | Navitor, Aveir, Mitraclip |
| Shockwave Medical, INC | $238.61 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $223.25 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $214.27 | 2023-2025 | |
| Novo Nordisk INC | $196.20 | 2023-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $162.00 | 2024-2025 | |
| Medtronic Vascular, INC. | $159.66 | 2019 | |
| Baxter Healthcare | $137.08 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $134.94 | 2023-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $119.38 | 2022-2025 | Verquvo |
| Philips North America LLC | $86.63 | 2023-2024 | (5044) Mcot |
| Actelion Pharmaceuticals US, INC. | $73.61 | 2023-2025 | Opsumit, Uptravi |
| Bard Peripheral Vascular, INC. | $69.62 | 2025 | Rotarexs 6 F X 135 Cm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.25 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $52.06 | 2024 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $44.72 | 2024 | |
| Biosense Webster, INC. | $44.59 | 2024 | Carto 3 |
| Kowa Pharmaceuticals America, INC. | $41.67 | 2022-2023 | Livalo |
| Sanofi-Aventis U.S. LLC | $27.94 | 2023 | |
| Heartflow, INC. | $24.55 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $22.60 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $20.87 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $19.52 | 2025 | Pascal |
| Scpharmaceuticals INC. | $12.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahender Gaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.